Edgen Stock·Dec 16 2025, 23:30Back
FDA Approves AstraZeneca's New Cancer Drug Combination
Edgen Stock·Dec 16 2025, 23:30
[1] AstraZeneca, Daiichi's breast cancer drug gets FDA nod as first-line treatment - Reuters (https://www.reuters.com/business/healthcare-p ...)[2] Disruptive Innovation in Cancer Research: The New Era of Oncology - BioSpace (https://www.biospace.com/disruptive-innovatio ...)[3] Hotspot mutations in HER2 interfaces destabilize structure, causing breast cancer treatment failure - Nature (https://www.nature.com/articles/s41388-025-03 ...)
